JP and RT were supported in part by a grant from Fondazione Umberto Veronesi entitled “Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases (MMPS) as biomarkers of bladder cancer development and progression”. This evidence concerns the gene LCN2 and urinary bladder carcinoma.